CD8+ and CD4+ TRM cells were identified in human brain and in lesions of MS patients [212,213], and recent research primarily focused on the role of CD8+ TRM cells and their contribution to autoimmune pathology in MS and EAE [212,213,214,215,216]. Here, CD8A is linked to myeloid sarcoma.